Episode 59 - How Clinical Insight Drives Better Pharmacy Outcomes with Employers Health

Employers Health’s clinical team anchors its pharmacy strategy in evidence‑based criteria rather than pure cost‑cutting. By combining pharmacy expertise with business acumen, the team designs utilization‑management protocols that prioritize safety, efficacy, and member experience. This proactive approach moves beyond traditional prior‑authorization tactics, modeling criteria on real‑world drug data to ensure that clinical outcomes drive every decision.

A distinctive advantage lies in the partnership with PBMs and the early deployment of custom clinical edits. Employers Health delivers bespoke formulary adjustments two to three years before PBMs typically adopt them, translating into measurable savings across dermatology, obesity, and diabetes programs. Regular standing calls with PBM partners enable real‑time pipeline monitoring and collaborative refinement of programs, allowing the collective’s $6 billion pharmacy spend to benefit from innovations that larger PBMs cannot scale for every client. The focus on biosimilars further illustrates this impact, as targeted advocacy reduces specialty spend while smoothing provider and member transitions to interchangeable products.

For employers selecting a benefits partner, clinical expertise is no longer optional—it’s essential for controlling drug mix, per‑member‑per‑month costs, and overall plan performance. The team’s deep dive into clinical trials, biosimilar interchangeability, and nuanced drug comparisons equips sponsors with transparent, data‑driven recommendations. By avoiding fee‑laden, white‑labeled PBM programs and offering flexible, fee‑free solutions, Employers Health empowers plan sponsors to align pharmacy benefits with strategic cost‑containment and member‑centric goals, ultimately delivering better health outcomes and sustainable financial results.